Biocon Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 706.50 | 1,234.50 | 598.90 |
| Operating Expense | 581.80 | 531.50 | 487.80 |
| Net Profit | 21.20 | 584 | 3.20 |
| Net Profit Margin | 3.00 | 47.31 | 0.53 |
| Earning Per Share | 0.18 | 4.88 | 0.03 |
| EBIDTA | 137.40 | 691.50 | 106.60 |
| Effective Tax Rate | 21.25 | 1.19 | 11.88 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 706.50 |
| Operating Expense | 581.80 |
| Net Profit | 21.20 |
| Net Profit Margin | 3.00 |
| Earning Per Share | 0.18 |
| EBIDTA | 137.40 |
| Effective Tax Rate | 21.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 2,242.60 | 2,127.30 | 1,992.90 |
| Operating Expenses Annual | 2,066.80 | 1,864.60 | 1,969.40 |
| Operating Profit Annual | 1,025.60 | 470.20 | 3,157.70 |
| Interest Annual | 236.90 | 198.80 | 69.60 |
| Depreciation | 122.40 | 114.10 | 108.30 |
| Net Profit Annual | 609.30 | 119.30 | 2,848.40 |
| Tax Annual | 51.60 | 31 | 122.80 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 2,242.60 |
| Operating Expenses Annual | 2,066.80 |
| Operating Profit Annual | 1,025.60 |
| Interest Annual | 236.90 |
| Depreciation | 122.40 |
| Net Profit Annual | 609.30 |
| Tax Annual | 51.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 122.30 | 196.60 | 111 |
| Cash Flow from Operations | 623.90 | -123.20 | 219.30 |
| Cash Flow from Investing | -991.50 | -294.70 | -1,173.10 |
| Cash Flow from Financing | 494.80 | 343.60 | 1,039.40 |
| Cash Flow at the End | 249.50 | 122.30 | 196.60 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 122.30 |
| Cash Flow from Operations | 623.90 |
| Cash Flow from Investing | -991.50 |
| Cash Flow from Financing | 494.80 |
| Cash Flow at the End | 249.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 18.43 | 21.31 | 13.60 |
| PBIT Margin (%) | 12.73 | 15.62 | 7.74 |
| PBT Margin (%) | 12.68 | 15.54 | 7.63 |
| Net PROFIT Margin (%) | 27.17 | 5.61 | 142.93 |
| Return On Networth / Equity (%) | 0.40 | 0.97 | -0.14 |
| Return On Networth /Employed (%) | 2.07 | 2.61 | 1.50 |
| Return On Assets (%) | 4.35 | 0.95 | 27.16 |
| Total Debt / Equity (X) | 0.22 | 0.15 | 0.07 |
| Asset Turnover Ratio (%) | 0.16 | 0.17 | 0.19 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 18.43 |
| PBIT Margin (%) | 12.73 |
| PBT Margin (%) | 12.68 |
| Net PROFIT Margin (%) | 27.17 |
| Return On Networth / Equity (%) | 0.40 |
| Return On Networth /Employed (%) | 2.07 |
| Return On Assets (%) | 4.35 |
| Total Debt / Equity (X) | 0.22 |
| Asset Turnover Ratio (%) | 0.16 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,074.10 | 915 | 914 |
| Total Current Assets Annual | 2,170.20 | 2,760 | 2,566 |
| Non Current Assets Annual | 13,450.90 | 11,008.20 | 10,463.90 |
| Total Shareholders Funds Annual | 11,524.40 | 10,912.30 | 10,916 |
| Total Assets Annual | 15,621.10 | 13,768.20 | 13,029.90 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,074.10 |
| Total Current Assets Annual | 2,170.20 |
| Non Current Assets Annual | 13,450.90 |
| Total Shareholders Funds Annual | 11,524.40 |
| Total Assets Annual | 15,621.10 |
EPS (INR)
Expected
2.87
Reported
2.88
Surprise
0.35%
Dec 2024
EPS beaten by 0.35%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
